RNS Number : 1016S
IndigoVision Group PLC
07 March 2019
 

7 March 2019

 

IndigoVision Group plc

("IndigoVision", the "Company" or the "Group")

 

Final Results for the year ended 31 December 2018

 

The Board of IndigoVision is pleased to report the financial results for the year ended 31 December 2018.

Financial highlights

·      Revenue up 9% to $46.0m (2017: $42.1m as restated for IFRS 15)

·      Gross margin increased by 3.4% to 57.4%, driven by increased software sales

·      Operating loss $0.6m (2017 loss: $2.8m)

·      Underlying operating loss $0.6m (2017: Underlying operating loss1 $2.4m)

·      Net cash balance of $2.0m at 31 December 2018 (2017: $2.6m)

·      Basic and diluted loss per share 4.1 cents (2017: loss per share 34.9 cents)

·      Adjusted loss per share 4.1 cents (2017 adjusted loss per share2: 29.6 cents)

·      No final dividend proposed (2017: nil)

 

Operational highlights

·      Key US market sales growth 20%

·      Authorised resellers increased by 10% and new value added reseller channel established

·      Launch of Integra®, all-in-one appliance aimed at the SME market

·      Replacement Ultra camera range launched and new camera supply sources currently under development

·      Max Thowless-Reeves replaces George Elliott as Chairman, with George remaining as a Non-executive Director

·      Martin Pengelley to retire from the Board at the forthcoming AGM

 

Pedro Simoes, Chief Executive, commented:

"I am pleased with the progress we have made to date, in strengthening our sales team, growing our customer base and opening up a new value added distribution channel. The launch of a number of new products has helped reposition the business and facilitate growth. In 2018, our software revenues grew by approximately one quarter year-on-year and we continue to seek out new technology partnerships to bring value to our customers through IndigoVision's Control Center video management software."

 

1 Underlying operating loss represents operating loss of $2.8m prior to the exceptional compensation and settlement costs of $0.40m

2 Adjusted loss per share is based on the 2017 loss after tax of $2.6m prior to the exceptional compensation and settlement costs of $0.40m

Enquiries to:

 

IndigoVision Group plc

Pedro Simoes (CEO)

+44 (0) 131 475 7200


Chris Lea (CFO)


N+1 Singer, Nominated Adviser

Sandy Fraser

+44 (0) 20 7496 3176

Charlotte Street Partners, Media Enquiries

 

Malcolm Robertson

Martha Walsh

+44 (0) 7788 567680

+44 (0) 7876 245962

 

Chairman's statement

Overview

This time last year, I indicated the Group's financial performance in 2017 and indeed, prior years, had not been acceptable and that IndigoVision was not achieving its full potential. The change of leadership undertaken in 2017 was designed to reverse this and it is taking effect. There is a high pace of internal change and momentum is building throughout the Group. This momentum has been reflected in the significantly improved operational performance in 2018 and is expected to continue into 2019 and beyond.

I am pleased to report that under the stewardship of the new leadership team, the Group has increased revenue by 9%, improved the gross margin by 3.4 percentage points and reduced the operating loss by $2.2m as compared with 2017. The Group made an operating loss of $0.6m in the year ended 31 December 2018 compared to an operating loss of $2.8m the previous year. Despite this substantial improvement, there remains much work still to be done to return the Group to an acceptable level of profitability and this remains the focus for the Board and the leadership team for the year ahead.

Strategy

As reported previously the Group's strategy to grow its market share and profitability is to:

·      increase and improve the quality of its sales presence in key geographies;

·      develop differentiated products in collaboration with other software developers to meet the growing demand for cyber security and intelligent video security systems;

·      work closely with our OEM partners; and

·      improve productivity and efficiency and control costs.

Sales

During the year the significant investment made in strengthening the Group's sales presence in North America in 2017, in particular in the United States, has begun to yield results. 

In addition, the number of authorised system integrators that resell the Group's products has increased by 10% during the year. Furthermore, following the development of new products targeted at small and medium sized enterprises, the Group has opened up a new value added reseller channel, with 19 new distributors located in strategic markets.

Product roadmap

The Group's current product range has been reviewed and repositioned to be more competitive. New products in the pipeline have also been assessed to ensure that priority is given to the benefits and features that our customers need and to focus on cyber security and artificial intelligence. Relationships with third party software developers have also been strengthened during the year.

Relationship with equipment suppliers

We are working closely with our hardware equipment suppliers to provide our customers with the best integrated end-to-end solutions for their security needs, allowing them to take maximum advantage of IndigoVision's software. In September 2018, the US Government introduced a 10% tariff on cameras manufactured in China and, depending on the ongoing bi-lateral trade negotiations between the two countries, there is the possibility that this tariff will increase to 25% in the very near term. In response to this change, the Group's primary camera supplier is opening a production facility in Central America and the Group is broadening its supply chain to offer cameras manufactured in other parts of Asia, both of which initiatives should mitigate the impact of any incremental duties.

BREXIT

Whilst the majority of the Group's products are manufactured outside the European Union, certain network video recorders are manufactured within the EU. The Group has recently increased inventory within its UK warehouse and has developed contingency plans to minimise supply interruption in the event of a no-deal Brexit. With supply locations in the UK, USA and Malaysia, the Group has inherent flexibility within its supply chain to enable it to meet customer demand throughout any transitionary arrangements after 29 March 2019.

 

Results

Revenue in the year ended 31 December 2018 was $46.0m, in line with expectations. Overall revenues were $3.9m (9%) higher than 2017 ($42.1m, as restated for the adoption of IFRS 15).

Regional sales performance continues to be mixed, with revenue growth of 45% in APAC, 8% growth in North America (including 20% growth in the USA), 5% growth in EMEA, but a 9% decline in Latin America.

Encouragingly, gross margin improved substantially in the year to 57.4% from 54.0% in 2017, continuing the upward trend seen since the latter half of 2016. This was achieved, primarily, by increased software sales, improved warranty cost management and a shift towards more profitable geographic markets.

The overall result for the year was an operating loss of $0.6m (2017: $2.8m). The operating loss before exceptional items was $0.6m (2017: $2.4m). Included within these results were professional fees of $0.2m in relation to acquisitions which were not completed (2017: $nil) and an FX loss of $0.2m (2017: FX gain of $0.3m). The first time adoption of IFRS 15 has increased the 2018 operating loss by $0.3m (2017: nil), through the net deferral of extended warranty income to subsequent periods.

 

Board Changes

The last eighteen months have seen substantial changes in the Board, which have in turn driven rapid and far-reaching changes in both the strategic direction and operation of the business. The Board recognises the need to provide additional support to the executive management team. I am therefore pleased to confirm that one of my fellow non-executive directors, Max Thowless-Reeves, has agreed to dedicate additional time to the affairs of the Group and will become Chairman with immediate effect. Unfortunately, my other business commitments do not allow me to devote the necessary time to undertake this role, but I will remain as a non-executive director of the Company.

Martin Pengelley has indicated his intention to retire from the Board at the forthcoming AGM and I should like to thank him for his contribution over the last five years. The Board expects to announce Martin's replacement shortly.

 

Cash and Dividends

The net cash balance at 31 December 2018 was $2.0m (2017: $2.6m). The Group is in the latter stages of negotiating a new invoice finance facility, to provide additional working capital to facilitate organic and acquisitive growth and replaces the $4.0m overdraft facility previously provided by Royal Bank of Scotland plc.

The Company will not pay a dividend this year (2017: nil).

 

Outlook

The Board and senior management expect to make further significant progress in delivering the Group's strategy and returning the business to profitability in 2019.

Operational Review

 

2018 started to show positive results of the new strategic direction set during the previous year. The significant investment made in strengthening the Group's sales presence in North America in 2017, in particular in the United States, has started to pay off. In addition, the number of authorised system integrators that resell the Group's products has increased by 10% during the year and, following the development of new products targeted at small and medium sized enterprises, the Group has opened up a new value added reseller channel, with 19 new distributors located in strategic markets.

During the first half of 2018 the Group launched a range of new products and services including the Integra all-in-one device, which combines video storage and Control Center video management software in a single piece of hardware. The product targets the SME market, and has attracted a strong pipeline of orders since its launch in April. The Group also enhanced its patent-pending CyberVigilant® technology, using software to identify and report on anomalies within a customer's CCTV network. This second generation of IndigoVision's cyber technology is now embedded within the camera, allowing for real time protection at the edge of the network and differentiating the Company's products from the competition.

On 13 August 2018, the US Government enacted legislation, the National Defense Authorization Act (NDAA), placing restrictions on the use of certain named manufacturers' hardware products, either for standalone supply or as a substantial or essential component or as critical technology within any system for US government and US government-funded contracts; the legislation takes effect in fiscal year 2019.

In addition, the impact and extent of tariffs, especially in relation to the distribution of Chinese manufactured product into the US, remains dynamic. The high pace of change in this regard brings a corresponding amount of uncertainty, however the Group does not currently foresee these factors impacting materially on its ability to fulfil contractual commitments in the US. Also our developing supply chain partnerships and flexibility diminish our reliance on specific companies and Chinese manufacturers.

Markets and Products

IndigoVision products are deployed in many market sectors for a variety of customers from small and medium sized enterprises to large and multinational corporations. The Group is particularly well known in the enterprise markets of airports, safe cities, banks, casinos and law enforcement. End users value the quality, reliability and scalability of the IndigoVision system, together with the end-to-end customised solutions achieved through an extensive suite of integration modules with operational and other security software. 2018 saw major project wins in safe city projects, airports, shopping malls and a number of casinos.

IndigoVision's product strategy continues to be the design and sale of complete end-to-end video security solutions, inclusive of video management software, cameras, encoders, storage devices and integration to security and operational systems. There are few competitors that provide full end-to-end solutions, and buyers value the system reliability inherent in designing the complete solution, as well as the ease of one-stop sourcing. 

Business Model

IndigoVision designs and manufactures high performance, video security systems for a wide range of users from large scale and complex security installations to small, eight camera systems. From video capture and transmission to analysis and storage, IndigoVision networked video security systems provide the best quality and most secure video evidence, using market leading compression technology to minimise network bandwidth usage and reduce storage costs.

The Group develops its end-to-end networked video systems through in-house design, use of OEM manufacturers and working with technology partners. Product is manufactured in Asia and Europe and brought into inventory based on forecast sales.

The Group utilises both in-house and third party warehouses in Europe, North America and Asia to store product, enabling timely order despatch to its global customer base and offering local product repair services.

The Group sells its products and services through a global network of authorised partners who install the Group's systems at end user sites. The Group's partners vary in size from large international security companies to local system integrators; value added resellers; and distributors in limited geographies. These companies offer first line technical support to end users and can maintain the system post sale. The Group provides second line technical support to authorised partners.

The Group is structured into four regional sales and support teams, with people in 23 countries, generating sales across many more countries.

Strategy

Key areas of strategic development for the business include:

 

Technology innovation

New products are brought to market regularly to maintain the Group's competitive position as technology advances. The Group operates a dual development strategy of in-house software development and OEM product sourcing and qualification. The in-house engineering team ensures all products supplied within the end-to-end offering are tested robustly and fully optimised as a complete solution to deliver market leading performance and reliability. Hardware life-cycles in the security market are reducing and, by sourcing products from a number of suppliers, the Group can offer a broader product range and increase speed to market for new technology. The Group's in-house development resource is strategically weighted towards software development, to meet increased market demand for intelligent video systems for both security and operational needs.

 

The Group continues to look at exciting partnership opportunities to combine IndigoVision's scale and technology base with emerging technology providers to create further innovative new products, possibly including bolt-on acquisitions of complementary technologies.

 

Sales and marketing

New and repeat business is being won continually; new markets have been developed in line with the Group's strategy; key customer relationships are monitored on a regular basis and the performance of the regional sales teams is continually reviewed to ensure appropriate development is provided and teams resourced accordingly. The sales and marketing team structure is evolving to manage the targeted growth.

 

Supply chain and logistics

The Group sources products from multiple suppliers in Asia and Europe, and consolidates these in three main logistics centres in Malaysia, the USA and the UK, operated by third parties. The Group also operates service centres in Colombia and Brazil. The Group continually strives to improve efficiency in the supply chain and logistics functions, to provide market leading service to our global customer base.

 

Employees

The continuing success of the Group primarily depends on its employees across the world, who contribute daily to the achievement of the organisational goals. The Group respects its staff and recognises that they are its most valuable asset. The Group recruits and retains staff globally by offering challenging opportunities, competitive compensation packages and a good working environment.

The Group strives to provide a working environment which encourages continuous learning and development for all employees and is committed to effective investment in training and development to achieve its business goals. The Group conducts an annual staff engagement survey to gauge employees' professional and emotional commitment to the Group and to seek feedback to drive continuous improvement.

The Group is committed to employee involvement throughout the business and operates a number of share option, share incentive and long term incentive plans which were adopted in 2018, along with a variety of cash bonus schemes. The Group has established an employee benefit trust in connection with these share option plans.

 

Financial Review

 

Results

In the year to 31 December 2018 revenue was $46.0m (2017: $42.1m), an increase of 9%. Three of the four sales regions achieved sales growth in 2018, with APAC recording year on year growth of 45%. North America and EMEA achieved growth of 8% and 5% respectively. Latin American sales were 9% lower than 2017.

 

Software sales achieved an increase of 26%, with the sale of licences up by 32%.   The value of software upgrade plans which entitle customers to receive new versions of IndigoVision Control Center software increased by 35%, the benefit of which will be seen in future years. The Company's premium "Ultra" software still accounts for the vast majority of licence sales, although recent changes to enhance the functionality of the Pro and Lite versions of the software are expected to yield volume increases. Camera volumes increased by 18% but average prices continued to fall. Overall, camera revenues increased by 8%.

 

Storage revenue declined 2% in the year, with further pressure on selling prices.  Storage now represents 26% of revenue (2017: 29%)

 

In line with the Group's strategic focus on the North American market, the Group implemented a major change in its North American operations in 2017, with a number of changes in personnel, strengthened management, expanded sales and sales support team and a re-positioning of the IndigoVision brand. North American revenues grew 8% in 2018 (2017: 6%). Revenue growth in the key US market was 20%.

 

Within EMEA, performance was mixed with growth in the Middle East & India, as well as in Southern Europe and France offsetting falls in the UK, Northern Europe & Sub-Saharan Africa. Middle East & India growth was 47%, almost completely reversing the 53% fall in 2017.

Difficult market conditions continue in Latin America with sales in the region falling by 9%. There are promising signs however, with the southern part of the region achieving sales growth of 55%.

APAC revenues grew by 45%, represented by growth of 35% in Australia, 267% in China where the Group's software was selected for Shanghai Pudong Airport, to manage a network of 9,100 cameras, and 26% in South East Asia.

The gross margin improved substantially in the year to 57.4% from 54.0% in 2017, continuing the trend seen since the latter half of 2016. This was achieved through an increasing proportion of software within overall revenue, better control over sales pricing, improved warranty cost management with the increasing proportion of OEM hardware passing more warranty risk back to the supplier and a shift towards more profitable geographic markets.

 

Overheads (excluding foreign exchange), at $26.8m, were 4% higher than last year (2017: $25.9m). This includes an increase of 16% in engineering costs, which now represent 7% of revenue (2017: 6%). Research and development spend has been increased to enable the Group to continue to differentiate its offering through innovation, with research and development now focused on software-led end-to-end video security.

 

The operating loss for the year was $0.6m compared to a loss of $2.8m in 2017. This loss is stated after expensing $0.2m in relation to acquisitions which were not completed (2017: $nil), together with a foreign exchange loss of $0.2m (2017: foreign exchange gain of $0.3m). The first time adoption of IFRS 15 has increased the 2018 operating loss by $0.3m (2017: $nil), through the net deferral of extended warranty income to subsequent periods.

Cash

The net cash balance at 31 December 2018 was $2.0m (2017: $2.6m). Cash balances are mainly held in US dollars, sterling, euros and Canadian dollars. Cash reserves in excess of current requirements are placed on a variety of term deposits. Term deposits are placed with banks from the list of the Group's approved institutions.  Cash on term deposits is included within cash and cash equivalents on the balance sheet.

During the year, The Royal Bank of Scotland plc indicated that it would be withdrawing the Group's unutilised overdraft facility of $4.0m. The Group is in the latter stages of negotiating a new invoice finance facility to provide additional working capital to facilitate organic and acquisitive growth.

Dividends

It is the Board's policy that dividends should reflect earnings and, given the full year loss, the Company will not pay a dividend this year.

 

 

Consolidated statement of comprehensive income

For the year ended 31 December 2018

 

 

 

Note

 

 

2018

 

$'000

2017

Restated*

$'000

Revenue

3

45,964

42,100

Cost of sales


(19,567)

(19,327)

Gross profit


26,397

22,773

Research and development expenses


(3,311)

(3,090)

Selling and distribution expenses


(19,114)

(17,081)

Administrative expenses


(4,406)

(5,699)

Foreign exchange (loss)/gain


(206)

281

Operating loss

4

(640)

(2,816)

Analysed as:




Underlying operating loss


(640)

(2,420)

Exceptional salary costs

4

-

(396)





Financial income

6

1

12

Loss before tax


(639)

(2,804)

Income tax credit

7

337

204

Loss for the period attributable to equity holders of the parent


 

(302)

(2,600)





Analysed as:




Underlying loss for the period attributable to equity holders of the parent


(302)

(2,204)

Exceptional salary costs

4

-

(396)

 

Other comprehensive income








Foreign exchange translation differences on foreign operations


(133)

(255)

Total comprehensive loss for the year attributable to equity holders of the parent

 

 

 

(435)

 

(2,855)

Basic loss per share (cents)

8

(4.1)

(34.9)

Diluted loss per share (cents)

8

(4.1)

(34.9)

Adjusted loss per share (cents)

8

(4.1)

(29.6)

 

 

Consolidated Balance Sheet

As at 31 December 2018


Note

 

2018

 

$'000

2017

Restated*

$'000

 

Non-current assets




Property, plant and equipment

9

989

1,504

Intangible assets

10

352

352

Deferred tax

12

1,732

1,846

Total non-current assets


3,073

3,702

Current assets




Inventories

13

8,011

8,936

Trade and other receivables

14

14,691

13,100

Cash and cash equivalents

15

2,024

2,574

Total current assets


24,726

24,610

Total assets


27,799

28,312

Current liabilities




Trade and other payables

16

9,188

10,081

Provisions

17

138

138

Total current liabilities


9,326

10,219         

Non-current liabilities




Provisions

17

45

45

Other non-current liabilities

18

1,932

1,117

Total non-current liabilities


1,977

1,162

Total liabilities


11,303

11,381

Net assets


16,496

16,931

 

Equity




Called up share capital

19

120

120

Share premium account

19

2,684

2,684

Other reserve

19

8,080

8,080

Translation reserve

19

(729)

(596)

Treasury/own share reserve

19

(268)

(268)

Profit and loss account


6,609

6,911

Total equity attributable to equity holders of the parent


16,496

16,931

 

Statement of changes in equity

For the year ended 31 December 2018

 

 

 

Group

Share capital

Share premium

Other reserve

Treasury / own share reserve

Translation reserve

Retained earnings

Total equity

$'000

$'000

$'000

$'000

$'000

$'000

$'000

Balance at 31 December 2016

120

2,684

8,080

-

(341)

9,243

19,786









Total comprehensive income








Loss for the year

-

-

-

-

-

(2,600)

(2,600)

Difference on translation

-

-

-

-

(255)

-

(255)

Total comprehensive income

-

-

-

-

(255)

(2,600)

(2,855)









Transactions with the owners of the Company








Equity-settled transactions, including deferred tax effect

-

-

-

-

-

-

-

Purchase of own shares

-

-

-

(268)

-

268

-

Dividends paid to equity holders

-

-

-

-

-

-

-

Total transactions with the owners of the Company

-

-

-

(268)

-

268

-

Balance at 31 December 2017

120

2,684

8,080

(268)

(596)

6,911

16,931

 

Total comprehensive income








Loss for the year

-

-

-

-

-

(302)

(302)

Difference on translation

-

-

-

-

(133)

-

(133)

Total comprehensive income

-

-

-

-

(133)

(302)

(435)

Transactions with the owners of the Company








Equity-settled transactions, including deferred tax effect

-

-

-

-

-

-

-

Purchase of own shares

-

-

-

-

-

-

-

Dividends paid to equity holders

-

-

-

-

-

-

-

Total transactions with the owners of the Company

-

-

-

-

-

-

-

Balance at 31 December 2018

120

2,684

8,080

(268)

(729)

6,609

16,496

 

Consolidated statement of cash flows

For the year ended 31 December 2018

 


2018

 

$'000

2017

Restated*

$'000

Cash flows from operating activities



Loss for the year

(302)

(2,600)

Adjusted for:



Depreciation and amortisation

886

850

Financial income

(1)

(12)

Share based payment expense

25

36

Foreign exchange loss/(gain)

206

(281)

Loss on disposal of fixed assets

37

104

Income tax credit

(337)

(204)

Decrease/(increase) in inventories

925

(864)

Increase in trade and other receivables

(1,591)

(328)

(Decrease)/increase in trade and other payables

(78)

1,797

Cash generated absorbed by operations

(230)

(1,502)

Income taxes repaid

228

179

Net cash outflow from operating activities

(2)

(1,323)

Cash flows from investing activities



Interest received

1

12

Acquisition of property, plant and equipment

(275)

(1,139)

Acquisition of intangible assets

(133)

(414)

Proceeds from the sale of fixed assets

-

28

Net cash outflow from investing activities

(407)

(1,513)

Cash flows from financing activities



Purchase of own shares

-

(268)

Finance lease payments

(19)

(18)

Dividends paid

-

(289)

Net cash outflow from financing activities

(19)

(575)

Net decrease in cash and cash equivalents

(428)

(3,411)

Cash and cash equivalents at 1 January

2,574

6,203

Effect of exchange rate fluctuations on cash held

(122)

(218)

Cash and cash equivalents at 31 December

2,024

2,574

 

Notes to the consolidated financial statements

 

1. Significant accounting policies

IndigoVision Group plc (the "Company") is a company domiciled and registered in Scotland. The consolidated financial statements of the Company for the year ended 31 December 2018 comprise those of the Company and its subsidiaries (together referred to as the "Group").

The address of its registered office is:

 

Charles Darwin House

The Edinburgh Technopole

Milton Bridge

Edinburgh

Midlothian

EH26 0PY

The financial statements were authorised for issue by the directors on 6 March 2019.

(a) Statement of compliance

Both the Company financial statements and the Group financial statements have been prepared and approved by the Directors in accordance with International Financial Reporting Standards as adopted by the EU ("Adopted IFRSs"). On publishing the Company financial statements here together with the Group financial statements, the Company is taking advantage of the exemption in s408 of the Companies Act 2006 not to present its individual income statement and related notes that form a part of these approved financial statements.

(b) New Accounting Standards and Interpretations adopted

The Group has adopted all of the new or amended Accounting Standards and Interpretations issued by the International Accounting Standards Board ('IASB') that are mandatory for the current reporting period.

Any new or amended Accounting Standards or Interpretations that are not yet mandatory have not been early adopted.

The following Accounting Standards and Interpretations are most relevant to the consolidated entity:

 (i) IFRS 9 Financial Instruments

The Group has adopted IFRS 9 from 1 January 2018. The standard introduced new classification and measurement models for financial assets. A financial asset shall be measured at amortised cost if it is held within a business model whose objective is to hold assets in order to collect contractual cash flows which arise on specified dates and that are solely principal and interest. A debt investment shall be measured at fair value through other comprehensive income if it is held within a business model whose objective is to both hold assets in order to collect contractual cash flows which arise on specified dates that are solely principal and interest as well as selling the asset on the basis of its fair value. All other financial assets are classified and measured at fair value through profit or loss unless the entity makes an irrevocable election on initial recognition to present gains and losses on equity instruments (that are not held-for-trading or contingent consideration recognised in a business combination) in other comprehensive income ('OCI'). Despite these requirements, a financial asset may be irrevocably designated as measured at fair value through profit or loss to reduce the effect of, or eliminate, an accounting mismatch. For financial liabilities designated at fair value through profit or loss, the standard requires the portion of the change in fair value that relates to the entity's own credit risk to be presented in OCI (unless it would create an accounting mismatch). New simpler hedge accounting requirements are intended to more closely align the accounting treatment with the risk management activities of the entity. New impairment requirements use an 'expected credit loss' ('ECL') model to recognise an allowance. Impairment is measured using a 12-month ECL method unless the credit risk on a financial instrument has increased significantly since initial recognition in which case the lifetime ECL method is adopted. For receivables, a simplified approach to measuring expected credit losses using a lifetime expected loss allowance is available.

(ii) IFRS 15 Revenue from Contracts with Customers

The Group has adopted IFRS 15 from 1 January 2018. The standard provides a single comprehensive model for revenue recognition. The core principle of the standard is that an entity shall recognise revenue to depict the transfer of promised goods or services to customers at an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The standard introduced a new contract-based revenue recognition model with a measurement approach that is based on an allocation of the transaction price. This is described further in the accounting policies below.

Credit risk is presented separately as an expense rather than adjusted against revenue. Contracts with customers are presented in an entity's statement of financial position as a contract liability, a contract asset, or a receivable, depending on the relationship between the entity's performance and the customer's payment. Customer acquisition costs and costs to fulfil a contract can, subject to certain criteria, be capitalised as an asset and amortised over the contract period.

The impact on the financial performance and position of the Group from the adoption of these Accounting Standards is detailed in note 2.

(c) Basis of preparation

The financial statements are presented in US Dollars, rounded to the nearest thousand. They are prepared on the historical cost basis.

(i) Going concern

As part of its going concern review the Board has followed the guidelines published by the Financial Reporting Council entitled 'Going Concern and Liquidity Risk Guidance for UK Companies 2009'. In determining the appropriate basis of preparing the financial statements, the Directors are required to consider whether the Company can continue in operational existence for the foreseeable future, being a period of not less than 12 months from the date of the approval of the financial statements. As at 31 December 2018 the Group had cash and cash equivalents of $2.0m and net current assets of $13.8m.

Management prepares detailed working capital forecasts which are reviewed by the Board on a regular basis. Cash flow forecasts and projections have been prepared through to December 2020 and take into account sensitivities on revenues and costs. Having made relevant and appropriate enquiries, including consideration of the Company's and the Group's current cash resources and the working capital forecasts, the Directors have a reasonable expectation that the Company and the Group will have adequate cash resources to continue to meet the requirements of the business for at least the next 12 months. Accordingly, the Board continues to adopt the going concern basis in preparing the financial statements.

(ii) Management judgement, estimates and assumptions

The preparation of financial statements in conformity with adopted IFRSs requires management to make judgements, estimates and assumptions that affect the application of policies and reported amounts of assets and liabilities, income and expenses. The estimates and associated assumptions are based on historical experience and various other factors that are believed to be reasonable under the circumstances, the results of which form the basis of making the judgements about carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates.

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised if the revision affects only that period or in the period of the revision and future periods if the revision affects both current and future periods.

Judgements made by management in the application of adopted IFRSs that have a significant effect on the financial statements and estimates with a significant risk of material adjustment in the next period are discussed in note 27.

The accounting policies set out below have been applied consistently to all periods presented in the consolidated financial statements.

(d) Basis of consolidation

(i) Subsidiaries

Subsidiaries are entities controlled by the Company. Control exists when the Company has the power to direct relevant activities.  In assessing control, potential voting rights that presently are exercisable or convertible are taken into account. The financial statements of subsidiaries are included in the consolidated financial statements from the date that control commences until the date that control ceases.  All subsidiaries are 100% controlled.

(ii) Transactions eliminated on consolidation

Intra-group balances, and income and expenses arising from intragroup transactions, are eliminated in preparing the consolidated financial statements. Exchange gains and losses on intra-group balances remain on consolidation.

(iii) Investments in subsidiaries

Investments by the Company in subsidiaries are carried at cost less provision for any impairment. The sterling value of the investments are translated to US dollars at the exchange rates ruling at the balance sheet date for presentation purposes in the Company financial statements.

(e) Foreign currency

(i) Functional currency

The Group's earnings stream is primarily US dollars and the principal functional currency is the US dollar, being the most representative currency of the Group. The Group's financial statements are therefore prepared in US dollars.

The exchange rates used in the preparation of the financial statements are stated in note 23.

 (ii) Foreign currencies

Income statements of entities whose functional currency is not US dollars are translated into US dollars at average rates of exchange for the period and assets and liabilities are translated into US dollars at the rates of exchange ruling at the balance sheet date. Exchange differences arising on translation of net assets in such entities held at the beginning of the year, together with those differences resulting from the restatement of profits and losses from average to year end rates, are taken to the currency translation reserve. 

In each individual entity, transactions in overseas currencies are translated into the relevant functional currency at the exchange rates ruling at the date of the transaction. Where more than one exchange rate is available, the appropriate rate at which assets can be readily realised and liabilities can be extinguished is used. Monetary assets and liabilities denominated in foreign currencies are retranslated at the exchange rates ruling at the balance sheet date. Any exchange differences are taken to the income statement.

(f) Property, plant and equipment

(i) Owned assets

Items of property, plant and equipment are stated at cost less accumulated depreciation (see below). Cost includes expenditure that is directly attributable to the acquisition of the asset.

Where parts of an item of property, plant and equipment have different useful lives, they are accounted for as separate items of property, plant and equipment.   

(ii) Depreciation

Depreciation is charged to the income statement on a straight-line basis over the estimated useful life of each part of an item of property, plant and equipment. The estimated useful lives are as follows:

·    Fixtures and fittings             3 - 10 years

·      Plant and equipment                      3 - 5 years

·      Computer hardware                        3 years

·      Demonstration  Equipment             2 years

The residual value and useful lives are reassessed annually.

(iii) Finance lease assets

Leases under which the Group assumes substantially all the risks and rewards of ownership of the leased asset are classified as finance leases. Leased assets acquired by way of finance lease are stated at an amount equal to the lower of their fair value and the present value of the minimum lease payments at inception of the lease, less accumulated depreciation and impairment losses. Lease payments are accounted for as described below.

(g) Intangible assets

(i) Research and development

Expenditure on research activities, undertaken with the prospect of gaining new scientific or technical knowledge and understanding, is recognised in the income statement as an expense as incurred.

An internally generated intangible asset arising from the Group's product development is recognised only if all of the following conditions are met:

·    an asset is created that can be identified;

·      the project from which the asset arises meets the Group's criteria for assessing technical feasibility;

·      it is probable that the asset created will generate future economic benefits; and

·      the development cost of the asset can be measured reliably.

Internally generated intangible assets are amortised on a straight line basis over their useful lives. Where no internally generated intangible asset can be recognised, development expenditure is recognised as an expense in the period in which it is incurred.

(ii) Computer software

Acquired computer software is capitalised on the basis of the costs incurred to acquire and bring into use the specific software. These costs are amortised using the straight line method over the software's estimated useful lives (one to three years). Costs associated with developing or maintaining computer software programmes are recognised as an expense as incurred.

(h) Trade and other receivables

Trade and other receivables are stated at their fair value as reduced by appropriate allowances for specific estimated irrecoverable amounts and a general provision, where necessary, following the adoption of IFRS 9.

(i) Inventories

Inventories are stated at the lower of cost and net realisable value. Net realisable value is the estimated selling price in the ordinary course of business, less the estimated costs of completion and selling expenses.

The cost of inventories is based on the average cost principle and is the expenditure incurred in acquiring the inventories and bringing them to their existing location and condition.

(j) Cash and cash equivalents

Cash and cash equivalents comprise cash balances and call deposits. Bank overdrafts or other short term debt facilities that are repayable on demand and form an integral part of the Group's cash management are included as a component of cash and cash equivalents for the purpose of the statement of cash flows.

(k) Impairment

The carrying amounts of the Group's assets, other than inventories (see accounting policy (i)), trade and other receivables (see accounting policy (h)) and deferred tax assets (see accounting policy (s)), are reviewed at each balance sheet date to determine whether there is any indication of impairment. If any such indication exists, the asset's recoverable amount is estimated (see accounting policy (k(i))).

An impairment loss is recognised whenever the carrying amount of an asset exceeds its recoverable amount. Impairment losses are recognised in the income statement.

 (i) Calculation of recoverable amount

The recoverable amount of assets is the greater of their fair value less costs to sell and value in use. In assessing fair value, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset. For an asset that does not generate largely independent cash inflows, the recoverable amount is determined for the cash-generating unit to which the asset belongs.

(ii) Reversal of impairment

An impairment loss is reversed if there has been a positive change in the estimates used to determine the recoverable amount.

An impairment loss is reversed only to the extent that the asset's carrying amount does not exceed the carrying amount that would have been determined, net of depreciation or amortisation, if no impairment loss had been recognised.

(l) Share capital

Ordinary shares are classified as equity.  Incremental costs directly attributable to the issue of ordinary shares are shown in equity as a deduction from equity. Dividends are recognised as a liability in the period in which they are approved by the shareholders.

(m) Employee benefits

(i) Defined contribution pension plans

Obligations for contributions to defined contribution pension plans are recognised as an expense in the income statement as incurred.

(ii) Share-based payment transactions

The Group's share option programme allows eligible employees to acquire shares in the Company. The fair value of options granted is measured at grant date and recognised as an expense with a corresponding increase in equity spread over the period during which the employees become unconditionally entitled to the options. The fair value is measured using the Black-Scholes option valuation model, taking into account the terms and conditions upon which the options were granted. The amount recognised as an expense is adjusted to reflect the number of share options for which the related service and non-market vesting conditions are expected to be met, such that the amount ultimately recognised as an expense is based on the number of share options that meet the related service and non-market performance conditions at the vesting date, except where forfeiture is only due to share prices not achieving the threshold for vesting.

The proceeds received net of any directly attributable expenses are credited to share capital and share premium when the options are exercised.

Where the Company grants share options to the employees of its subsidiaries, it recognises an increase in the cost of its investment in its subsidiaries equivalent to the equity settled share based payment charge in the consolidated financial statements.  The corresponding credit is recognised in equity.

(iii) Long term incentive plans

The Company has established the IndigoVision Group plc 2008 and 2018 Long Term Incentive Plan (the LTIPs). All employees and executive directors of the Group are eligible to be granted awards. The grant date fair value of conditional shares and share option awards (including unitised awards under the 2018 LTIP) is recognised as an employee expense, with a corresponding increase in equity, over the period in which the employees become unconditionally entitled to the shares. The fair values of the awards are measured using a valuation model, taking into account the terms and conditions upon which the LTIPs were granted.

(iv) Share Incentive Plans

The Group has established a number of share incentive plans to enable all employees and sales agents to purchase or notionally purchase shares in the Company, as set out in note 22.

The Company matches each share purchased through the UK employee scheme on a 1:1 basis. The fair value of the free matching share is measured using the Black-Scholes option valuation model, taking into account the terms and conditions upon which the shares were granted. The fair value is spread over the three year vesting period.

(m) Employee benefits

The IndigoVision Inc 2010 Restricted Stock Unit Plan, the International Agents Incentive Plan and the International Employee's Incentive Plan are cash settled plans. The Company matches each share notionally purchased through these schemes on a 1:1 basis. The Group accounts for the liability for the free notional share by marking to market at each financial period end.

(n) Employee share trusts

The Company has established a share trust, "The IndigoVision Group plc Employee Benefit Trust" which is separately administered and funded by loans from the Company. The Company recognises the assets and liabilities of the Trust in its own accounts.

(o) Provisions

A provision is recognised in the balance sheet when the Group has a present legal or constructive obligation as a result of a past event, and it is probable that an outflow of economic benefits will be required to settle the obligation.

A provision for warranties is recognised when the underlying products are sold. The provision is based on historical warranty data and a weighting of a range of possible outcomes against their associated probabilities.

(p) Trade and other payables

Trade and other payables are not interest bearing and are stated at their fair value.

(q) Revenue

Revenue comprises income from the sale of goods, income from technical support activities, income from the sales of software upgrade contracts for between one and five years in length, royalty income earned during the period, and excludes sales taxes.

(i) Product revenues

Revenue from the sale of goods is recognised in the income statement when the significant risks and rewards of ownership have been transferred to the buyer, in line with individual Incoterms®, which is normally when the goods have been despatched from the warehouse or are available for customer collection.

(ii) Technical support activities

Revenue from technical support activities is recognised on completion of the service.

(iii) Software upgrade contracts

Revenue from the sale of software upgrade contracts for between one and five years in length is deferred on the balance sheet and recognised in the income statement on a straight-line basis over the length of the contract.

(r) Expenses

(i) Operating lease payments

Payments made under operating leases are recognised in the income statement on a straight-line basis over the term of the lease.

(ii) Net financing income

Net financing income comprises interest payable on the bank overdraft facility and interest receivable on cash deposits.

(iii) Finance lease payments

Minimum lease payments are apportioned between the finance expense and the reduction of the outstanding liability. The finance expense is allocated to each period during the lease term so as to produce a constant periodic rate of interest on the remaining balance of the liability.

(s) Income tax

The tax expense represents the sum of the current taxes payable and deferred tax. Tax is recognised in the income statement except to the extent that it relates to items recognised directly in equity, in which case it is recognised in equity.

The current tax payable is based on taxable income for the period using tax rates that have been enacted or substantively enacted by the balance sheet date.

Deferred tax is the tax expected to be payable or recoverable on differences between the carrying amounts of assets and liabilities in the financial statements and the corresponding tax bases used in the computation of taxable profit, and is accounted for using the balance sheet liability method. Deferred tax liabilities are generally recognised for all taxable temporary differences and deferred tax assets are recognised to the extent that it is probable that taxable profits will be available against which deductible temporary differences can be utilised within a reasonable period of time. The carrying amount of deferred tax assets is reviewed at each balance sheet date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow the asset recognised to be recovered within a reasonable period of time. Deferred tax is calculated using tax rates that are enacted or substantively enacted at the balance sheet date.

(t) Earnings per share

Basic earnings per share is calculated by dividing the profit and loss attributable to ordinary shareholders of the Company by the weighted average number of ordinary shares in issue during the period, excluding shares held by the Employee Benefit Trust and shares held in treasury, which are treated as cancelled. Diluted earnings per share is determined by adjusting the weighted average number of ordinary shares outstanding for the effects of potentially dilutive ordinary shares, which comprise share options granted.

(u) New standards and interpretations not yet adopted

The 2018 financial statements have been prepared in accordance with International Financial Reporting Standards (IFRSs) as adopted by the European Union.

 

The IASB and the IFRIC have also issued the following standards and interpretations with an effective date after the date of the financial statements:

 

New standards and Interpretations Endorsed but not yet Effective

1.   IFRS 16  Leases (effective date 1 January 2019)

 

New standards and Interpretations not yet Endorsed and not yet Effective

-      IFRS 14 Regulatory Deferral Accounts IFRIC 23

·      Uncertainty over Income Tax Treatments (effective date 1 January 2019)

-      Amendments to IAS 28

·      Investments in Associates and Joint Ventures (effective date 1 January 2019)

 

A full assessment of the impact of the above standards and interpretations has yet to be made.

 

2. Restatement of comparatives

(a) Adoption of IFRS 9 'Financial Instruments' and IFRS 15 'Revenue from Contracts with Customers'

This note explains the impact of the adoption of IFRS 15 Revenue from Contracts with Customers on the Group's financial statements.

 

The Group has adopted IFRS 15 Revenue from Contracts with Customers from 1 January 2018 which resulted in changes in accounting policies and adjustments to the amounts recognised in the financial statements. In accordance with the transition provisions in IFRS 15, the Group has adopted the new rules retrospectively and has restated comparatives for the 2017 financial year.

 


Consolidated statement of comprehensive income as originally presented

31 December 2017

$000

 

IFRS 15

 

 

$000

Restated consolidated statement of comprehensive income

31 December 2017

$000

Revenue

42,331

(231)

42,100

Cost of sales

(19,558)

231

(19,327)

 


Balance sheet carrying amount

31 December 2017

$000

 

Restatement

 

$000

IFRS 15 carrying amount

1 January 2018

$000

Trade and other receivables

12,869

231

13,100

Trade and other payables

(10,950)

(231)

(11,181)

 

The above adjustments were made to the amounts recognised in the consolidated statement of comprehensive income and balance sheet as at the date of initial application (1 January 2018) and are in relation to the deferral of warranty income and the related costs.  The adjustments do not impact the 2017 year reported profits or net assets.

 

Following an assessment of two years of allowances and recovery of bad debts, any additional impairment allowance relating to the IFRS 9 would be immaterial.

(b) Correction of misstatement relating to the Employee Benefit Trust (Company only)

The 2017 Company balance sheet has been restated to consolidate the assets of the Employee Benefit Trust, removing loans to the Trust from related party debtors and offsetting the cost of shares held in the Trust against reserves.  This reduces debtors and reserves in 2017 by $708,000 and in 2016 by $647,000.

3. Segment reporting

The Board reviews the Group's internal reporting in order to assess performance and to allocate resources. The Board assesses the performance of the following geographical sales regions: primarily Europe; Middle East and Africa; North America; Latin America; and Asia Pacific and has therefore determined these as the operating segments. 

The Board considers the performance of the operating segments based on regional sales and Group-wide gross margin before warranty costs.  The operating segments derive their revenue from the sale of software, hardware products and services. Capital is not allocated to geographical regions and substantially all of the Group's income and expenditure is incurred by its UK trading subsidiary, IndigoVision Limited.  The information currently provided to the Board is measured in a manner which is consistent with the financial statements.

Segment information is also presented in the respect of the Group's products and services which have different economic characteristics, including the sale of end-to-end video security solutions, consultancy services and multi-year software upgrade plans.

Operating segments

Regional Sales

 

2018

$'000

Restated*

2017

$'000

Europe, Middle East and Africa

19,419

18,423

North America

13,149                   

12,174

Latin America

5,513

6,078

Asia Pacific

7,883

5,425


45,964

42,100               

* See note 2 for details regarding the restatement as a result of change in accounting policy.

All sales are to third parties and all segment results are from continuing activities. The gross margin earned in each region is comparable and the majority of overheads are incurred centrally and are therefore unallocated to each region.

Revenues derived from external customers based in the UK were $6,421,000 (2017: $6,794,000).

Analysis of revenue


2018

$'000

2017

$'000

Revenues from:



Products/solutions

33,599

32,238

Support services

35

113

Software licences

8,989

6,808

Software Upgrade Contracts

3,341

2,941


45,964               

42,100               




 

4. Operating loss




2018

$'000

2017

$'000

Operating loss is stated after charging:




Depreciation and amortisation


886               

850                

Exceptional salary costs1


-

396

Foreign exchange loss/(gain)


206

(281)

(Recovery of)/allowance for doubtful trade receivables


(234)

385

Net write down of inventories to realisable value


321                 

379                 

Research & development expenditure


3,311

3,090

Share based payment expense


25

36

Fees payable to the Group's auditor:




Audit of the financial statements (Group and Company)


33

17

Audit of subsidiary companies


20

33

Tax compliance and advisory


35

9

All other services


17

3

 

1The exceptional salary costs relate to compensation and settlement payments made to the former CEO who resigned on 23 November 2017.

 

5. Personnel expenses

Group


2018

$'000

2017

$'000

Wages and salaries


9,725                

8,913                

Compulsory social security contributions


833                 

878                 

Contributions to defined contribution pension plans


593                  

566                  

Equity-settled share based payment transactions


25                     

36                     



11,176              

10,393              

The figures above include the Directors' remuneration, including compensation for loss of office, which is disclosed separately in the Directors Remuneration Report.

Average number of employees, including Executive Directors and excluding retained agents, by activity


 

2018

Number

 

2017

Number

   Selling and distribution

63

59

   Research & Development

36

32

   Administration

25

25



124

116

 

No personnel expenses are paid directly by the Company.

 

6. Net financing income

 

Group


2018

$'000

2017

$'000

Bank interest receivable


-

10

Interest charged on accounts receivable

1

2

Net financial income


1

12

 

7. Income taxes



2018

$'000


2017

$'000

Current tax expense/(credit)





UK tax


(336)


(236)

UK tax - prior year adjustment


(127)


188

Overseas tax


10


12

Overseas tax - prior year adjustment


2


(9)



(451)


(45)

Deferred tax expense/(credit)





Origination and reversal of temporary differences


-


(180)

Reduction in tax rates


-


21

Adjustments relating to prior year trading losses


114


-



114


(159)

Total income tax expense/(credit) in income statement


(337)


(204)






Recognised in the income statement

The Group trades principally through its UK subsidiary, IndigoVision Limited. The current tax credit relates to research and development expenditure at 14.5%

The extent to which a deferred tax asset is recognised is dependent on estimates of future trading over an extended period of time and the extent to which research and development costs may be eligible for research and development tax credits in the future. The Group anticipates increasing its investment in research and development proportional to sales growth.

Based on the Group's trading assumptions the deferred tax asset is expected to begin being realised from 2020 onwards, when the Group starts to generate taxable profits and will be realised over a period of five years. As a result, the deferred tax asset has been valued based upon a future UK Corporation tax rate of 17%.

The deferred tax asset is denominated in sterling and as such is subject to exchange rate fluctuations. Such exchange rate movements are dealt with as part of the deferred tax income or expense for the year.

 

Reconciliation of effective tax rate


2018


2017


%

$'000


%

$'000

Loss before tax


(639)



(2,804)

Income tax using the UK corporation tax rate

18.97

(121)


19.25

(540)

Other permanent differences

(1.57)

10


0.18

(5)

Non-deductible expenses

(12.70)

81


(1.18)

33

Fixed asset timing difference

(0.78)

5


(0.14)

4

Deduction for R&D expenditure

68.00

(433)


3.99

(112)

Surrender of tax losses for R&D tax credit refund

(17.40)

111


(6.38)

179

Deferred tax not recognised

(20.69)

132


-

-

Tax losses utilised

0.16

(1)


-

-

Adjustments to brought forward balances

(1.88)

12


(0.78)

22

Adjust deferred tax to average rate of 19%

(0.31)

2


-

-

Prior year adjustment - current tax

19.91

(127)


 (6.63)

 186

Temporary difference not recognised in computation

2.66

(17)


-

-

Exchange difference arising on movement between opening and closing spot rates - current tax

-

-


0.14

(4)

Overseas taxes credit

(1.88)

12


(0.43)

12

Effect of tax rate change on deferred tax asset

0.47

(3)


(0.75)

21

 Total

52.96

(337)


17.97

(204)

 

At 31 December 2018 tax losses generated outside the UK available for offset against future profits, amounted to approximately $1.7m (2017: $1.9m); using an income tax rate of 19.00% (2017: 19.25%) this is equivalent to an asset of $0.3m (2017: $0.4m). However, due to continuing uncertainty over the timing of suitable profits and the fact that such losses will eventually time expire, no asset is currently being recognised in the consolidated financial statements in respect of such losses.

 

8. Earnings per share



2018

$'000


2017

$'000

Earnings per share





Loss for the year attributable to equity shareholders (basic and diluted)


(302)


(2,600)

Exceptional compensation and settlement costs


-


396






Adjusted loss for the year attributable to equity shareholders


(302)


(2,204)








Cents


Cents

Basic earnings per share


(4.1)


(34.9)

Diluted earnings per share


(4.1)


(34.9)

Adjusted earnings per share


(4.1)


(29.6)

 

The weighted average number of ordinary shares used in the calculation of basic and diluted earnings per share for each period were calculated as follows:


2018

Number of shares

2017

Number of shares

Issued ordinary shares at start of year

7,610,756

7,610,756

Effect of purchase of own shares

(229,238)

(170,763)

Weighted average number of ordinary shares for the year - for earnings per share

7,381,518

7,439,993

 

Basic earnings per share

The calculation of basic earnings per share for the year ended 31 December 2018 was based on the loss attributable to equity shareholders of $302,000 (2017 loss: $2,600,000) and a weighted average number of ordinary shares during the year ending 31 December 2018 of 7,381,518 (2017: 7,439,993), calculated as shown above.

Diluted earnings per share

The calculation of diluted earnings per share for the year ended 31 December 2018 was based on the loss attributable to equity shareholders of $302,000 (2017 loss: $2,600,000) and a weighted average number of ordinary shares during the year ending 31 December 2018 of 7,381,518 (2017: 7,439,993), calculated as shown above.

Adjusted earnings per share

The calculation of adjusted earnings per share for the year ended 31 December 2018 was based on the loss attributable to equity shareholders of $302,000 (2017 loss: $2,600,000), to which the exceptional compensation/settlement costs of $nil (2017: $396,000) have been added back. A weighted average number of ordinary shares during the year ending 31 December 2018 of 7,381,518 (2017: 7,439,993), calculated as shown above. Adjusted earnings per share has been presented to reflect the one-off nature of the exceptional salary costs incurred in 2017. The Board believes an adjusted earnings per share measure is required to reflect its view of the underlying performance and to align more closely with management targets and rewards.

9. Property, plant and equipment

Group

Plant and

equipment

Fixtures and

fittings

Computer

hardware

Demo

equipment

Total


$'000

$'000

$'000

$'000

$'000

Cost






At 31 December 2016

1,638

1,081

1,387

1,666

5,772

Additions

313

9

220

597

1,139

Disposals

(28)

-

(2)

(651)

(681)

At 31 December 2017

1,923

1,090

1,605

1,612

6,230

Additions

91

1

86

97

275

Disposals

-

-

-

(64)

(64)

At 31 December 2018

2,014

1,091

1,691

1,645

6,441







Depreciation






At 31 December 2016

1,407

515

1,253

1,361

4,536

Depreciation charge for the period

189

118

103

357

767

Disposals

(7)

-

(3)

(567)

(577)

At 31 December 2017

1,589

633

1,353

1,151

4,726

Depreciation charge for the year

175

113

110

355

753

Disposals

-

-

-

(27)

(27)

At 31 December 2018

1,764

746

1,463

1,479

5,452







Net Book Value






At 31 December 2016

231

566

134

305

1,236

At 31 December 2017

334

457

252

461

1,504

At 31 December 2018

250

345

228

166

989

 

 

Included in the net book value of computer hardware are assets held under finance leases of $17,000 (2017:

$34,000) after charging depreciation of $17,000 (2017: $17,000).

 

There was no property, plant and equipment held in the Company at 31 December 2018.

 

10. Intangible assets

Group

 

Intangible assets under

Computer


Construction

software

Total

$'000

$'000

$'000

Cost




At 31 December 2016

-

564

564

Additions

-

414

414

Disposals

-

(19)

(19)

At 31 December 2017

-

959

959

Additions (assets under construction)

133

-

133

Disposals

-

-

-

At 31 December 2018

133

959

1,092





Amortisation and impairment losses




At 31 December 2016

-

542

542

Amortisation for the year

-

84

84

Disposals

-

(19)

(19)

At 31 December 2017

-

607

607

Amortisation for the year

-

133

133

Disposals

-

-

-

At 31 December 2018

-

740

740





Net book value




At 31 December 2016

-

22

22

At 31 December 2017

-

352

352

At 31 December 2018

133

219

352

 

There were no intangible assets held in the Company at 31 December 2018.

 

 

11. Investments in subsidiaries

Company

 

2018

$'000

2017

$'000

Cost



At start of period

2,337               

2,135               

Increase in respect of share based payments

25                   

36                    

Difference on translation

(145)

166

At end of period

2,217

2,337                

 

 

All subsidiaries



Ownership interest (direct)


Registered office address

Country of incorporation

 

2018 & 2017

%

IndigoVision Ltd

Charles Darwin House, Edinburgh Technopole, Milton Bridge, Penicuik, Midlothian, EH26 0PY

 

Scotland

100

 

IndigoVision Inc

300 Broadacres Drive, 4th Floor, Unit 415, Bloomfield, NJ 07003 -3153, United States of America

 

United States of America


100

IndigoVision Pte Ltd

80 Robinson Road, #02-00, Singapore, 068898

 

Singapore


100

IndigoVision Video Security Solutions Limited.

Avenida da Praia Grande, n.o 815, 4o andar, Edificio Centro Comercial Talento, Macau

 

Macau


100

IndigoVision Solucoes De Seguranca Eletronica Ltda.

Rua Cerro Cora, Numero 1.306, Vila Romana  ,Sao Paulo, Brazil, 05061-200

 

Brazil


100

IndigoVision UK Ltd

Condor House, 10 St Paul's Churchyard, London, EC4M 8AL

 

England & Wales


100

IndigoVision Australia Pty Ltd

Level 5, Deutsche Bank Place, 126 Phillip Street, Sydney, New South Wales, 2000

 

Australia


100

Indigo Vision Security System (Shanghai) Co., Ltd

Room 405, No. 553 Mao Tai Road, Chang Ning District, Shanghai, China, 200336

China


100

 

12. Deferred tax assets and liabilities

 

Recognised deferred tax assets

Deferred tax assets are attributable to the following:




2018

$'000

2017

$'000

Employee benefits - share based payments



24

24

Value of tax losses carried forward



1,671

1,785

Depreciation in excess of capital allowances



32

32

Other timing differences



5

5

Tax assets



1,732

1,846

 

Unrecognised deferred tax assets

Deferred tax assets have not been recognised in the current period in respect of the following items:




2018

2017

$'000

$'000

Tax losses - UK



3,009

3,407

Tax losses - Non UK



314

314




3,323

3,721

 

Movement in temporary differences during the period


1 January 2017

Recognised in income

31 December 2017

$'000

$'000

$'000

Employee benefits - share-based payments

24

-

24

Tax value of losses carried forward

1,626

159

1,785

Depreciation in excess of capital allowances

32

-

32

Other timing differences

5

-

5


1,687

159

1,846

 


1 January 2018

Recognised in income

31 December 2018

$'000

$'000

$'000

Employee benefits - share-based payments

24

-

Tax value of losses carried forward

1,785

(114)

Depreciation in excess of capital allowances

32

-

Other timing differences

5

-

5


1,846

(114)

1,732

 

13. Inventories




 

2018

2017

$'000

$'000

Raw materials and consumables



234

309

Finished goods



7,777

8,627         




8,011         

8,936         

 

The write-down of inventories to net realisable value amounted to $321,000 (2017: $379,000). In the 12 month period, raw material, consumables and changes to finished goods recognised as cost of sales amounted to $19,423,000 (2017: $19,415,000).

 

14. Trade and other receivables

 


Group


Company


2018

$'000

2017

$'000


2018

$'000

2017

$'000

Trade receivables

11,907     

10,485     


-

-

Amounts due from subsidiary undertakings

-

-


1,637     

1,478     

Other receivables

2,165          

1,843          


16

-

Prepayments and accrued income

619           

772           


-

-


14,691

13,100      


1,653     

1,478     

The Group's exposure to credit and currency risks and impairment losses related to trade and other receivables are disclosed in note 23.

 

15. Cash and cash equivalents

 


Group

 


Company

 


2018

$'000

2017

$'000


2018

$'000

2017

$'000

Bank balances and cash and cash

equivalents in the statement of cash flows

2,024

2,574     


22

437

The Group's exposure to interest rate risk is disclosed in note 23.    The overdraft facility is secured by a floating charge over the assets of the business.

 

16. Trade and other payables


Group


Company


2018

$'000

2017

$'000


2018

$'000

2017

$'000

Trade payables

5,227     

6,086     


-

-

Taxation and social security

235

395


-     

-     

Finance lease assets: due with one year

13

19


-

-

Other payables

180          

740          


39

-

Accruals

1,357

862


-

-

Deferred income

2,176           

1,979           


-

-


9,188

10,081      


39     

-     

 

 

17. Provisions

Group product warranties


2018

$'000

2017

$'000

Balance at start of period

183

183

Provision made during the period

479

796

Provision used during the period

(479)

(796)

Balance at the end of the period

183

183

Non-current

45

45

Current

138

138


183

183

 

The provision relates to possible claims on products sold during the standard warranty period granted at the point of sale. The provision has been based on analysis of product introductions and instances of actual goods returned and is expected to be utilised within the next two years.

 

18. Other non-current liabilities

Group

 


2018

2017

$'000

$'000

Finance lease assets: due in more than one year


-

14

Deferred income


1,600

1,100

Extended Warranty


329

-

International Agents Incentive plan


3                

3



1,932

          1,117





 

19. Capital and reserves


Ordinary shares


2018

2017

Number of shares

Number of shares

In issue at start of period

7,610,756                  

7,610,756                  

Issued for cash on exercise of employee share options

-                        

-                        

In issue at end of period - fully paid

7,610,756

7,610,756                  

 

At 31 December 2018, the issued share capital comprised 7,610,756 ordinary shares (2017: 7,610,756) which have a nominal value of 1 pence per share. All issued shares are fully paid.

The holders of ordinary shares are entitled to one vote per share at meetings of the Company and are entitled to receive dividends as recommended by the Directors. The holders of ordinary shares also have an unlimited right to share in the surplus remaining on winding up after all creditors are satisfied.

 

Share premium

The share premium arose primarily on 2 August 2000 when the Company was listed on the London Alternative Investment Market.

 

Translation reserve

The translation reserve comprises all foreign exchange differences from the 1 August 2006, the IFRS transition date, arising from the translation of the financial statements of the Company and subsidiaries where their functional currency is different from the Group's presentation currency.

 

Other reserve

The other reserve arose on the acquisition of IndigoVision Limited in 2000 prior to listing on the London Stock Exchange when merger accounting, which was permitted under applicable accounting standards at that time, was adopted. As this was before the date of transition to IFRS, advantage has been taken of the provisions of IFRS1 such that the accounting for this business combination has not been restated.

 

Treasury/own shares reserve

The total number of shares held in Treasury at 31 December 2018 was 97,238 (2017: 97,238).

 

Employee Benefit Trust

Offset within the profit and loss account is an amount of $848,579 (2017: $848,579) representing the cost of own shares held within the Employee Benefit Trust. The nominal value of own shares held is £1,320.

 

20. Finance Leases

 

Future lease payments are due as follows:





 

 

 

 

2018



Minimum lease payments

$'000

 

 

Interest

$'000

 

Present

value

$'000

Not later than one year



13

-

13

Between one year and five years



-

-

-

Later than five years



-

-

-




13

-

13







 







 

 

 

 

2017



Minimum lease payments

$'000

 

 

Interest

$'000

 

Present

value

$'000

Not later than one year



19

-

19

Between one year and five years



14

-

14

Later than five years



-

-

-




33

-

33







 

 

21. Contingent Liabilities

HMRC Duty deferment

The Group has provided a bank guarantee of £60,000 in relation to UK duty deferment.

 

22. Share based payments

 

Share option schemes

The Company has established a number of share option schemes that entitle Directors, senior management and other employees to purchase shares in the Company. Grants have been made of share options in the period from 2000 to date.

 

The Tax Advantaged Share Option Schemes

The Company currently operates  two tax advantaged, discretionary share options schemes: The 2008 Approved Share Option Scheme and the 2018 Company Share Option Scheme, with the latter being introduced during the year to replace the former, which had reached the end of its ten year life.

 

During 2017, the Company also operated the now terminated 2000 Approved Share Option Scheme.

 

Under these plans (which are intended to satisfy certain legislative requirements) the Remuneration Committee may grant selected eligible employees in the United Kingdom tax advantaged share options up to certain specified statutory limits.

 

The Unapproved Share Option Schemes

The Company has two "unapproved" share option schemes (being arrangements that are not intended to benefit from any particular tax advantages in the UK): The 2008 Unapproved Share Option Scheme and the 2018 Employee Share Option Scheme, with the latter being introduced during the year to replace the former, which had reached the end of its ten year life.

 

Under these plans the remuneration committee may grant selected eligible employees options that exceed the value limit of the HM Revenue and Customs tax advantaged share option plans. Options granted under this scheme may be exercised between three and ten years from the grant date.  The scheme is open to all employees.

 

Stand-Alone Option Agreements

The Remuneration Committee has sole discretion to grant share options through stand-alone option agreements to sales agents or other consultants or advisors to the Group. The Remuneration Committee can determine the terms and conditions that apply to each agreement.

 

The Long Term Incentive Plan (LTIP) 2008

On 3 June 2008, the Company established the IndigoVision Group plc 2008 Long Term Incentive Plan. This plan is intended to award share options and/or conditional share awards to selected employees of the Group.

 

The Share Incentive Plan 2010 (SIP)

On 10 August 2010, the Company established the IndigoVision Group plc Share Incentive Plan 2010, which is approved by HM Revenue and Customs and open to all employees in the United Kingdom.  Under the HM Revenue & Customs approved limits, employees may purchase from a minimum of £10 to a maximum of £150 worth of shares per month by means of a deduction made from gross pay. The Company matches each share purchased by employees on a 1:1 basis.  Employees may redeem their shares at anytime; however, if this is before the third anniversary of the purchase, the Company's matching shares will be forfeited. The SIP scheme is administered by the Yorkshire Building Society.

 

The Employee Benefit Trust

On 3 June 2008, in connection with establishing the Long Term Incentive Plan, the Company established the IndigoVision Group plc Employee Benefit Trust for the purpose of encouraging and facilitating the acquisition and holding of shares in the Company for the benefit of employees of the Group. As at 31 December 2018, 132,000 shares in the Company had been acquired by the Employee Benefit Trust.

 

The Long Term Incentive Plan (LTIP) 2018

On 24 October 2018, the Company established the IndigoVision Group plc 2018 Long Term Incentive Plan. Under the New LTIP, selected individuals were given the opportunity to share in a proportion of a "pool" of Ordinary Shares that is equal to 20% of the Company's entire issued share capital.

 

The amount of this pool that is actually distributed amongst participants is entirely dependent on the level of earnings per share ("EPS") that the Company delivers in its 2021 financial year. In particular:

·      the whole of the pool will be available for distribution to participants if the 2021 EPS figure is equal to or greater than $1.00;

·      for EPS of $0.20 or less, no part of the pool will be distributed (and all awards will immediately lapse); and

·      for performance between these two levels, the amount of the pool available to participants will be calculated by reference to a sliding scale (from 0% to 100%) that is more heavily weighted towards superior performance levels.

 

The shares to which a participant in the 2018 LTIP becomes entitled following the assessment of the above performance condition will be subject to further holding periods over the financial years ending 31 December 2022, 2023 and 2024. If the EPS in any of these subsequent years falls below the level delivered in 2021, a portion of the participant's award will immediately lapse and cease to exist.

 

On 21 November 2018, the following awards were made under the 2018 LTIP:



Number of units


Pedro Simoes


375


Chris Lea


375


Paul Theasby

Chief Operating Officer

250


 

Share option plans

The terms and conditions of grants are as follows, whereby all options are settled by physical delivery of shares:

 

 

 

Grant date

Number of instruments originally granted

                                   

 

 

Vesting conditions

Contractual life of options





The 2008 Approved Share Option Plan




29 April 2010

3,234

3 years from date of grant

10 years

20 April 2012

3,000

3 years from date of grant

10 years

9 January 2013

3,000

3 years from date of grant

10 years

19 December 2013

7,699

3 years from date of grant

10 years

26 March 2015

6,778

3 years from date of grant

10 years





The 2008 Share Option Plan




29 April 2010

1,766

3 years from date of grant

10 years

19 December 2013

2,801

3 years from date of grant

10 years

26 March 2015

9,222

3 years from date of grant

10 years





The Stand-Alone Option Agreements




19 December 2013

48,000

Individually determined (typically  3 years)

10 years

26 March 2015

75,000

Individually determined (typically  3 years)

10 years

15 March 2017

50,000

Individually determined (typically  3 years)

10 years





The Long Term Incentive Plan




26 March 2015

28,800

Individually determined (typically  3 years)

10 years

26 March 2015

140,500

Individually determined (typically  3 years)

10 years

15 March 2017

280,000

Individually determined (typically  3 years)

10 years

20 October 2017

100,000

Individually determined (typically  3 years)

10 years

 

The number and weighted average exercise prices of unexercised share options are as follows:


2018


2017


Weighted average exercise price £

Number of options


Weighted average exercise price £

Number of options

The 2000 Approved Share Option Plan






Outstanding at the beginning of the period

-

-


8.48

5,500

Forfeited during the period

-

-


8.48

(5,500)

Exercised during the period

-

-


-

-

Outstanding at the end of the period

-

-


-

-

The 2008 Approved Share Option Plan






Outstanding at the beginning of the period

3.75

24,711


3.70

33,246

Granted during the period

-

-


-

-

Forfeited during the period

3.75

(4,000)


3.53

(8,535)

Outstanding at the end of the period

3.75

20,711


3.75

24,711

The 2008 Unapproved Share Option Plan






Outstanding at the beginning of the period

3.68

13,789


3.62

29,254

Granted during the period

-

-


-

-

Forfeited during the period

 3.45

(6,000)


 3.56

(15,465)

Outstanding at the end of the period

3.85

7,789


3.68

13,789

The 2008 Stock Option Plan






Outstanding at the beginning of the period

-

-


3.59

2,000

Granted during the period

-

-


-

-

Forfeited during the period

-

-


3.59

(2,000)

Outstanding at the end of the period

-

-


-

-






Outstanding at the beginning of the period

1.10

163,650


1.56

131,600

Granted during the period

-

-


1.82

50,000

Forfeited during the period

0.94

(120,600)


3.59

(17,950)

Exercised during the period

 -

-


 -

-

Outstanding at the end of the period

1.55

43,050


1.10

163,650

The Long Term Incentive Plan






Outstanding at the beginning of the period

-

299,300


 -

86,800

Granted during the period

-

-


 -

380,000

Forfeited during the period

-

(30,000)


 -

(167,500)

Exercised during the period

 -

-


 -

-

Outstanding at the end of the period

-

269,300


-

299,300







 

The weighted average share price at the date of exercise of share options exercised during the 12 month period was £ nil (2017: £nil) as no options were exercised.

The options outstanding at the period-end have an exercise price in the range of £0.01 to £5.00 (2017: £0.01 to £5.00) and a weighted average remaining contractual life of 3.9 years (2017: 6.3 years).

 

The options outstanding at 31 December 2018 have an exercise price in the ranges summarised below:

Exercise Price Range


Number of options outstanding at 31 December 2018

Weighted average remaining contractual life (years)

£0.01- £3.44

35,000

2.7

£3.45 - £4.49

46,500

5.0

£4.50 - £5.00

5,000

1.3


86,500

3.9

The fair value of services received in return for share options is measured by reference to the fair value of share options granted. The estimate of fair value of the services received is measured based on the Black- Scholes model. The model has used an expected life of options of between 3.5 and 4 years, a risk free discount rate of between 1.19% and 5.75% and historical share price volatility at the date of grant range of between 33% and 72.2%.

 

The total charge recognised for the period arising from share based payments was $25,000 (2017: $36,000). Of this, $25,000 (2017: $36,000) arose from equity-settled share based payments.

 

Recognised in income statement


2018

$'000

2017

$'000

Share options granted in 2013

-

4

Share options granted in 2014

-

6

Share options granted in 2015

7

10

Share options granted in 2016

8

11

Share options granted in 2017

7

5

Share options granted in 2018

3

-

Total expense recognised as employee costs (note 5)

25

36

 

23. Financial instruments

The Group's principal financial instruments as at 31 December 2018 consist of cash and cash equivalents which are used to finance group operations together with trade receivables and trade payables which arise directly from the Group's operations.

 

During the periods ended 31 December 2018 and 31 December 2017, the Group did not use derivative financial instruments to hedge its exposure to foreign exchange and interest rate risks arising from operational, financing and investment activities. The Group does not hold or issue derivative financial instruments for trading purposes.

 

The Group is exposed to credit risk, interest rate risk, foreign currency risk and liquidity risk during the normal course of business.

 

Credit risk

At the balance sheet date there were no significant concentrations of credit risk. The exposure to credit risk is mitigated by selling to a wide range of customers and, where necessary, obtaining payments in advance or letters of credit. Credit evaluations are performed on all customers requiring credit. The Group establishes a specific allowance for impairment if a loss is estimated in respect of trade and other receivables.

 

Counterparties for cash and short-term deposits are restricted to financial institutions with high credit ratings.

 

The maximum exposure to credit risk is represented by the carrying amount of each financial asset in the balance sheet. As at the reporting date, the maximum exposure to credit risk was:



Group


Company


Note 

2018

$'000

2017

$'000


2018

$'000

2017

$'000

Trade and other receivables

14

14,072

12,328


1,653

1,478

Cash and cash equivalents

15

2,024

2,574


22

437



16,096   

14,902


1,675  

1,915  

The Company has limited exposure to trade receivables as receivable balances are due from group companies and related parties.

 

The exposure to credit risk for trade receivables at the reporting date by geographical region was:



2018

2017

$'000

$'000

Europe, Middle East and Africa


5,354

5,868            

North America


3,841

2,726

Latin America


2,284

1,868

Asia Pacific


1,634

1,512            



13,113          

11,974          

 

Impairment losses

The aged profile of trade receivables at the reporting date was:



Gross

Impairment


Gross

Impairment


2018

$'000

2018

$'000

2017

$'000

2017

$'000

Not past due


6,529

-


6,817

-

0-30 days overdue


3,946

-


1,705

-

31-60 days overdue


774

-


656

-

More than 61 days overdue


1,864

(1,206)


2,796

(1,489)



13,113

(1,206)


11,974

(1,489)

 

The allowance in respect of trade receivables is used to record impairment losses unless the Group is satisfied that no recovery of the outstanding amount is possible. At that point, the amount considered irrecoverable is written off against the trade receivables directly. Based on past experience, the Group believes no further impairment allowance is necessary in respect of trade receivables which are past due.

The movement in the allowance for impairment in respect of trade receivables during the period was as follows:



2018

$'000

2017

$'000

Balance at start of period


(1,489)

(1,454)

Impairment recognised


(109)

(681)

Impairment released


300

296

Effect of movements in foreign exchange


92

350

Balance at end of period


(1,206)

(1,489)

 

Interest rate risk

The Group earns interest from cash and cash equivalents with high credit rated financial institutions and pays interest on any bank overdraft balances. These are subject to interest rate movements.

 

Currency risk

The Group is exposed to foreign currency risk on sales, purchases, staff costs and sales agent costs that are denominated in a currency other than US dollars. The currencies giving rise to this risk are primarily sterling, euros and Canadian dollars.

The Group's revenue is denominated in US dollars (approximately 61% (2017: 55%)), sterling (approximately 14% (2017: 16%)), euro (approximately 18% (2017: 20%)) and Canadian dollars 7% (2017: 9%). The majority of the Group's cost of sales is denominated in US dollars. The majority of the Group's other operating expenses are in sterling.

 

For monetary assets and liabilities held in currencies other than US dollars, the Group ensures that the net exposure is kept to an acceptable level by buying and selling foreign currencies at spot rates where necessary to address short-term balances. 

 

The Group has investments in foreign operations whose net assets are exposed to currency translation risk. 

 

 

Financial assets and financial liabilities by currency

 

 

Note

2018

2017

$'000

$'000

Sterling trade and other receivables

14

2,314

1,855

Euro trade and other receivables

14

2,009

3,012

Other currency trade and other receivables

14

695

1,527

Sterling cash and cash equivalents

15

305

92

Euro cash and cash equivalents

15

76

377

Other currency cash and cash equivalents

15

105

316

Sterling trade and other payables

16 & 18

(1,702)

(2,183)

Other currency trade and other payables

  16 & 18

(195)

(766)

All of the Company's financial assets and liabilities are denominated in sterling.

 

The following significant exchange rates applied during the period

 



Average rate


Period end rate



12 months ended 31 December 2018

12 months ended 31 December 2017


31 December 2018

31December 2017

US dollar to sterling


0.7489

0.7759


0.7882

0.7394

US dollar to euro


0.8465

0.8861


0.8755

0.8326

 

Liquidity risk

The Group's exposure to liquidity risk is managed through the assessment of cash flow forecasts to ensure that sufficient funds are available to meet liabilities as they fall due. At 31 December 2018, the Group had an overdraft facility of $4.0m.This facility has recently been withdrawn by the Royal Bank of Scotland plc. As at 31 December 2018 the Group was not utilising the overdraft facility and had cash and cash equivalents of $2,024,000 (31 December 2017: $2,574,000). The Group does not have any interest bearing liabilities due after more than one year as the finance lease is interest free. 

 

The Group meets its day to day working capital requirements from operating cash flows and has not utilised the overdraft within the last two years.

The following are the contractual undiscounted cash flow maturities of financial liabilities.

 

As at 31 December 2018

Carrying

Contractual

6 months

6 - 12

1 - 2

2 - 5

Group

amount

cash flow

or less

months

years

years


$'000

$'000

$'000

$'000

$'000

$'000

Non-derivative financial liabilities







Trade and other payables

5,642

5,642

5,642

-

-

-

Finance lease assets

13

-

9

4

-

-


5,655

5,655

9

4

-

-

 

Capital management

The Board's policy is to maintain a strong capital base so as to maintain investor, creditor and market confidence and to sustain future development of the business. The capital structure of the Group consists of cash and cash equivalents and equity attributable to equity holders of the parent, comprising issued share capital, reserves and retained earnings as disclosed in the Group statement of changes in equity.  The Board monitors return on capital, which the Group defines as profit before tax divided by total assets less current liabilities.

 

Sensitivity analysis

In managing interest rate and currency risks the Group aims to reduce the impact of short-term fluctuations on the Group's earnings. Over the longer-term, however, permanent changes in foreign exchange and interest rates would have an impact on consolidated earnings. Currently there is not considered to be any material risk to the business on the basis of interest rate movements given the financial position of the Group.

 

It is estimated that a general increase of five percentage points in the value of sterling against the US dollar would have decreased the Group's profit before tax by approximately $0.4m for the year ended 31 December 2018 (2017: decrease of $0.3m) and a general increase of five percentage points in the value of the US dollar against the euro would have increased the Group's profit before tax by approximately $0.5m (2017: increase of $0.4m).

 

Fair values

The carrying value of cash and cash equivalents, trade and other receivables, and trade and other payables is deemed to reflect materially the fair value for both the Group and Company.

 


2018

2017

 

 

Group:

Carrying Amount

Fair

Value

Carrying Amount

Fair Value

$'000

$'000

$'000

$'000

Trade and other receivables

14,072

12,866

12,328

10,839

Cash and cash equivalents

2,024

2,024

2,574

2,574

Trade and other payables

(5,642)

(5,642)

(7,221)

(7,221)


10,454

9,248

7,681

6,192

 


2018

2017

 

 

Company:

Carrying Amount

Fair

Value

Carrying Amount

Fair

 Value

$'000

$'000

$'000

$'000

Trade and other receivables

16

16

-

-

Amounts due from subsidiary undertakings

1,637

1,637

1,478

1,478

Amounts due from other related parties





Cash and cash equivalents

22

22

437

437

Trade and other payables

(39)

(39)

-

-


1,636

1,636

1,915

1,915

 

24. Operating leases

Non-cancellable operating lease rentals are payable as follows.


2018

$'000

2017

$'000

Lease rentals due within:



Less than one year

599

582

Between one and five years

406

1,002

More than five years

-

-


1,005

1,584

 

During the year ended 31 December 2018, $640,000 was recognised as an expense in the income statement in respect of operating leases (2017: $533,000).

 

The Group leases premises in the UK, USA, Canada, Brazil, China and Dubai under operating leases. The UK head office lease expires in February 2021, the US lease expires April 2021 and the leases for all other premises expire in November 2019 or earlier.

 

25. Capital commitments

As at 31 December 2018 the Group had no contracts to purchase property, plant and equipment (2017: $nil).

 

26. Related parties

Identity of related parties

The Group has a related party relationship with its subsidiaries (see note 11) and with its Directors.

 

Transactions with key management personnel

The board has defined key management personnel as the Directors of the Company.

 

During the year the Group paid $215,000 to Cooper Software Limited, a company of which George Elliott was a director.

 

Directors of the Company and their immediate relatives control 2.34% of the voting shares of the Company.  Information regarding the Directors' shareholdings and share options is contained in the Directors' Report.

 

In addition to their salaries, the Group also contributes to a post-employment defined contribution plan on behalf of the Executive Directors. The Executive Directors also participate in the Group's share option schemes. Details of the Directors' remuneration are contained in the Directors' report on page 11.

 

During the year employer National Insurance contributions of $86,000 were made in relation to Directors' remuneration.

 

Transactions with subsidiaries

During the year the Company was charged a management fee of $216,000 (2017: $213,000) by its subsidiary IndigoVision Limited.

 

During the year the Company charged interest on cash balances loaned to its subsidiary IndigoVision Limited of $41,000 (2017: $40,000).

 

At the year end, IndigoVision Limited owed the Company $1,670,000, repayable on demand (2017: $1,468,000).

 

During the year the Company received no dividend from its subsidiary, IndigoVision Limited (2017: $nil).

 

27. Accounting estimates and judgements

Management discussed with the audit committee the development, selection and disclosure of the Group's critical accounting policies and estimates and the application of these policies and estimates.

 

Warranty provision

The provision for warranties is estimated based on historical warranty data which typically ranges from 1% to 3% per annum and management judgement on estimated future returns given the operational activities during the two year warranty period preceding the reporting date and the extent to which warranty costs can be passed back to third party manufacturers. If actual project installations or product failure rates are less favourable than those estimated by management or the costs associated with repair or replacement cannot be passed back to the manufacturer, then warranty costs may exceed the provision made at the reporting date.

 

Deferred tax asset

Deferred tax assets and liabilities require management judgement in determining the amounts to be recognised. In particular, judgement is used when assessing the extent to which deferred tax assets should be recognised, with consideration given to the timing and level of future taxable income and the availability or otherwise of research and development tax credits. As future taxable income is likely to deviate to some degree from forecasts, the amount of the deferred tax asset carried needs to be reviewed in the light of such variations.

 

Inventories

Inventories are stated at the lower of cost and net realisable value. Some items included in inventories are written down to their net realisable value based on assumptions about future demand and market conditions. If actual market conditions are less favourable than those projected by management, then inventory may require to be written down by additional amounts. The assessment of whether an inventory write down is required is dependent on the circumstances prevailing at the time of the assessment.

 

Trade receivables

Trade receivables require management judgements in determining the amounts recoverable. Trade receivables are stated net of any provision for doubtful debts. The assessment of whether a receivable is doubtful is dependent on the circumstances prevailing at the time of the assessment.

 

28. Availability of Report and Accounts

The report and accounts for the year ended 31 December 2018 will be posted to shareholders in due course, and a further update will be made as appropriate.

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
FR KMGGFZVNGLZZ